A detailed history of Geneos Wealth Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 32,215 shares of ABBV stock, worth $5.46 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
32,215
Previous 29,431 9.46%
Holding current value
$5.46 Million
Previous $5.05 Million 26.01%
% of portfolio
0.24%
Previous 0.23%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $456,130 - $554,934
2,784 Added 9.46%
32,215 $6.36 Million
Q2 2024

Jul 23, 2024

SELL
$154.79 - $180.76 $44,115 - $51,516
-285 Reduced 0.96%
29,431 $5.05 Million
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $134,728 - $153,510
-843 Reduced 2.76%
29,716 $5.41 Million
Q4 2023

Jan 26, 2024

SELL
$137.6 - $154.97 $601,174 - $677,063
-4,369 Reduced 12.51%
30,559 $4.74 Million
Q3 2023

Oct 11, 2023

SELL
$133.59 - $154.65 $209,068 - $242,027
-1,565 Reduced 4.29%
34,928 $5.21 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $329,419 - $409,941
2,486 Added 7.31%
36,493 $4.92 Million
Q1 2023

Apr 25, 2023

SELL
$144.61 - $166.54 $666,941 - $768,082
-4,612 Reduced 11.94%
34,007 $5.42 Million
Q4 2022

Jan 30, 2023

SELL
$138.31 - $165.87 $380,352 - $456,142
-2,750 Reduced 6.65%
38,619 $6.25 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $2.22 Million - $2.55 Million
-16,537 Reduced 28.56%
41,369 $5.55 Million
Q2 2022

Jul 22, 2022

SELL
$137.62 - $174.96 $75,415 - $95,878
-548 Reduced 0.94%
57,906 $8.87 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $557,219 - $691,352
-4,222 Reduced 6.74%
58,454 $9.48 Million
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $988,356 - $1.25 Million
-9,200 Reduced 12.8%
62,676 $8.49 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $68,521 - $77,782
644 Added 0.9%
71,876 $7.88 Million
Q2 2021

Jul 08, 2021

SELL
$105.21 - $117.21 $1.28 Million - $1.43 Million
-12,192 Reduced 14.61%
71,232 $8.2 Million
Q1 2021

Jun 17, 2021

BUY
$102.3 - $112.62 $165,009 - $181,656
1,613 Added 1.97%
83,424 $9.3 Million
Q4 2020

May 19, 2021

BUY
$80.49 - $108.67 $2.06 Million - $2.79 Million
25,643 Added 45.65%
81,811 $7.65 Million
Q3 2020

Sep 07, 2021

SELL
$85.91 - $100.83 $372,849 - $437,602
-4,340 Reduced 7.17%
56,168 $4.84 Million
Q2 2020

Sep 07, 2021

BUY
$73.37 - $98.18 $325,762 - $435,919
4,440 Added 7.92%
60,508 $5.82 Million
Q1 2020

Sep 07, 2021

BUY
$64.5 - $97.79 $282,058 - $427,635
4,373 Added 8.46%
56,068 $4.07 Million
Q4 2019

Sep 07, 2021

BUY
$72.13 - $90.25 $53,881 - $67,416
747 Added 1.47%
51,695 $4.61 Million
Q3 2019

Sep 07, 2021

BUY
$62.98 - $75.72 $10,643 - $12,796
169 Added 0.33%
50,948 $3.81 Million
Q2 2019

Sep 07, 2021

BUY
$65.7 - $83.98 $152,029 - $194,329
2,314 Added 4.77%
50,779 $3.69 Million
Q1 2019

Sep 07, 2021

SELL
$77.14 - $90.79 $33,324 - $39,221
-432 Reduced 0.88%
48,465 $3.91 Million
Q4 2018

Sep 07, 2021

BUY
$77.85 - $96.01 $90,695 - $111,851
1,165 Added 2.44%
48,897 $4.46 Million
Q3 2018

Sep 07, 2021

BUY
$88.91 - $98.84 $1.05 Million - $1.17 Million
11,844 Added 33.0%
47,732 $4.51 Million
Q2 2018

Sep 07, 2021

SELL
$89.78 - $106.23 $365,494 - $432,462
-4,071 Reduced 10.19%
35,888 $3.33 Million
Q1 2018

Sep 07, 2021

SELL
$92.01 - $123.21 $12,329 - $16,510
-134 Reduced 0.33%
39,959 $3.78 Million
Q4 2017

Sep 07, 2021

SELL
$89.56 - $98.21 $138,370 - $151,734
-1,545 Reduced 3.71%
40,093 $3.88 Million
Q3 2017

Sep 07, 2021

SELL
$69.85 - $89.22 $300,005 - $383,199
-4,295 Reduced 9.35%
41,638 $3.7 Million
Q2 2017

Sep 07, 2021

SELL
N/A
-1,163 Reduced 2.47%
45,933 $3.33 Million
Q1 2017

Sep 07, 2021

BUY
N/A
720 Added 1.55%
47,096 $3.07 Million
Q4 2016

Sep 07, 2021

SELL
N/A
-5,607 Reduced 10.79%
46,376 $2.9 Million
Q3 2016

Sep 07, 2021

BUY
N/A
7,152 Added 15.95%
51,983 $3.28 Million
Q2 2016

Sep 07, 2021

SELL
N/A
-1,178 Reduced 2.56%
44,831 $2.81 Million
Q1 2016

Sep 07, 2021

BUY
N/A
46,009
46,009 $2.64 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.